CA2494544A1 - Method of treating osteoarthritis - Google Patents
Method of treating osteoarthritis Download PDFInfo
- Publication number
- CA2494544A1 CA2494544A1 CA002494544A CA2494544A CA2494544A1 CA 2494544 A1 CA2494544 A1 CA 2494544A1 CA 002494544 A CA002494544 A CA 002494544A CA 2494544 A CA2494544 A CA 2494544A CA 2494544 A1 CA2494544 A1 CA 2494544A1
- Authority
- CA
- Canada
- Prior art keywords
- pain
- substituted
- dimethyl
- methyl
- carboxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40525002P | 2002-08-22 | 2002-08-22 | |
US60/405,250 | 2002-08-22 | ||
PCT/IB2003/003664 WO2004017952A1 (en) | 2002-08-22 | 2003-08-13 | Method of treating osteoarthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2494544A1 true CA2494544A1 (en) | 2004-03-04 |
Family
ID=31946834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002494544A Abandoned CA2494544A1 (en) | 2002-08-22 | 2003-08-13 | Method of treating osteoarthritis |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1539127A1 (ja) |
JP (1) | JP2006501238A (ja) |
KR (1) | KR20050058454A (ja) |
CN (1) | CN1678297A (ja) |
AU (1) | AU2003255937A1 (ja) |
BR (1) | BR0313883A (ja) |
CA (1) | CA2494544A1 (ja) |
IL (1) | IL166600A0 (ja) |
MX (1) | MXPA05001254A (ja) |
PL (1) | PL375742A1 (ja) |
TW (1) | TW200410677A (ja) |
WO (1) | WO2004017952A1 (ja) |
ZA (1) | ZA200501133B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004105801A1 (en) * | 2003-05-30 | 2004-12-09 | Warner-Lambert Company Llc | Animal model for the alleviation of pain using il-6 |
WO2005002557A1 (en) * | 2003-07-03 | 2005-01-13 | Warner-Lambert Company Llc | Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof |
US20050026979A1 (en) * | 2003-07-31 | 2005-02-03 | Maha Ghazzi | Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
DE102008000237A1 (de) | 2007-02-06 | 2008-08-07 | Basf Se | Phenol-Imidazolderivate zur Stabilisierung von polymerisationsfähigen Verbindungen |
IL181577A0 (en) * | 2007-02-26 | 2007-07-04 | Jacob Bar Tana | Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders |
US8530420B2 (en) * | 2008-12-16 | 2013-09-10 | Kaohsiung Medical University | Treatment of arthritis with parathyroid hormone |
TWI382841B (zh) | 2010-10-29 | 2013-01-21 | Univ China Medical | 用於抑制發炎之醫藥組合物 |
TW201902471A (zh) * | 2017-04-18 | 2019-01-16 | 美商珍費爾醫療公司 | 賈卡賓尼(gemcabene)、其醫藥上可接受之鹽、彼等之組成物及使用彼等之方法 |
EP3867222A4 (en) * | 2018-10-18 | 2022-07-06 | Gemphire Therapeutics Inc. | GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF |
CN114847223B (zh) * | 2022-02-19 | 2023-11-07 | 昆明理工大学 | 一种建立oa食蟹猴模型的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
CN1395555A (zh) * | 2000-01-25 | 2003-02-05 | 沃尼尔·朗伯公司 | 二羧酸醚钙、其制备方法、和用其治疗血管疾病和糖尿病的方法 |
US20030220374A1 (en) * | 2002-01-14 | 2003-11-27 | Pharmacia Corporation | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
-
2003
- 2003-08-13 CN CNA038199513A patent/CN1678297A/zh active Pending
- 2003-08-13 MX MXPA05001254A patent/MXPA05001254A/es unknown
- 2003-08-13 KR KR1020057003022A patent/KR20050058454A/ko not_active Application Discontinuation
- 2003-08-13 AU AU2003255937A patent/AU2003255937A1/en not_active Abandoned
- 2003-08-13 BR BR0313883-6A patent/BR0313883A/pt not_active IP Right Cessation
- 2003-08-13 WO PCT/IB2003/003664 patent/WO2004017952A1/en not_active Application Discontinuation
- 2003-08-13 JP JP2004530464A patent/JP2006501238A/ja not_active Withdrawn
- 2003-08-13 CA CA002494544A patent/CA2494544A1/en not_active Abandoned
- 2003-08-13 PL PL03375742A patent/PL375742A1/xx not_active Application Discontinuation
- 2003-08-13 EP EP03792585A patent/EP1539127A1/en not_active Ceased
- 2003-08-21 TW TW092123032A patent/TW200410677A/zh unknown
-
2005
- 2005-01-31 IL IL16660005A patent/IL166600A0/xx unknown
- 2005-02-08 ZA ZA200501133A patent/ZA200501133B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1539127A1 (en) | 2005-06-15 |
CN1678297A (zh) | 2005-10-05 |
TW200410677A (en) | 2004-07-01 |
IL166600A0 (en) | 2006-01-15 |
BR0313883A (pt) | 2005-07-19 |
KR20050058454A (ko) | 2005-06-16 |
WO2004017952A1 (en) | 2004-03-04 |
MXPA05001254A (es) | 2005-06-08 |
AU2003255937A1 (en) | 2004-03-11 |
PL375742A1 (en) | 2005-12-12 |
ZA200501133B (en) | 2008-01-30 |
JP2006501238A (ja) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200501133B (en) | Method of treating osteoarthritis | |
US20070203212A1 (en) | Method of treating osteoarthritis | |
US20040019053A1 (en) | Combination of an allosteric carboxylic inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib | |
US20050026979A1 (en) | Methods for treating inflammation and inflammation-associated diseases with a statin and ether | |
US20030199567A1 (en) | Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2 | |
US20040034086A1 (en) | Combination of an allosteric inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib | |
US20040034085A1 (en) | Combination of an allosteric inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib | |
US20040019054A1 (en) | Combination of an allosteric carboxylic inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib | |
US20030166706A1 (en) | Method of treating osteoarthritis | |
US20040023969A1 (en) | Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib | |
US20040019055A1 (en) | Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib | |
US20050004196A1 (en) | Pharmaceutical compositions including an ether and selective COX-2 inhibitor and methods for using such |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |